Stages:
Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
School of Medicine
Dr. rer. nat. med.
Biopharmacologist
2010
Principal (procurist, PoA), portfolio of 13 Lifescience startups in Biotech, Pharma, Medtech, digitalHealth and Dx, advisory board member in 5 portfolio companies
2022
2022
2020
2020
2020
2015
2021 - 2022
2021 - 2022
2017 - 2021
2017 - 2021
EXit 2021
2016 - 2020
2016 - 2020
2004 - 2018
Exit to The Economist in 2018
2007 - 2010
2007 - 2010